58
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Addressing uncertainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma

, , , &
Pages 1754-1757 | Received 27 Feb 2010, Accepted 24 May 2010, Published online: 14 Jul 2010

References

  • Wiernik PH. Serum CA125 and PSA concentrations in patients with lymphoma. Clin Adv Hematol Oncol 2008;6:527–531.
  • Clarke C, O'Malley C. Non-Hodgkin lymphoma. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, editors. SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute, SEER Program; 2007. pp. 235–242.
  • Bairey O, Blickstein D, Stark P, et al Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma. Leuk Lymphoma 2003;44:1733–1738.
  • Gui W, Wang T, Wang J, et al An improved prognostic parameter for non-Hodgkin's lymphoma based on the combination of three serum tumor markers. Int J Biol Markers 2008;23:207–213.
  • Bonnet C, Beguin Y, Fassotte MF, Seidel L, Luyckx F, Fillet G. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. Eur J Haematol 2007;78:399–404.
  • Batlle M, Ribera JM, Oriol A, et al Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients. Leuk Lymphoma 2005;46:1471–1476.
  • Zidan J, Hussein O, Basher W, Zohar S. Serum CA125: a tumor marker for monitoring response to treatment and follow-up in patients with non-Hodgkin's lymphoma. Oncologist 2004;9:417–421.
  • Zacharos ID, Efstathiou SP, Petreli E, et al The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma. Eur J Haematol 2002;69:221–226.
  • Benboubker L, Valat C, Linassier C, et al A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels. Ann Oncol 2000;11:1485–1491.
  • Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. pp. 51–70.
  • Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882–890.
  • Steyerberg EW, Vickers AJ, Cook NR, et al Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010;21:128–138.
  • Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004;329:168–169.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.